Novo Nordisk's pricing strategies from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of price tag gouging, mentioning the stark contrast involving U.S. rates and those in Europe and copyright. But Rybelsus and copyright do have